Navigation Links
Assurex Health Appoints Veteran P&G Consumer Products Executive Virginia Coleman Drosos President to Lead Personalized Medicine Growth
Date:9/9/2013

MASON, Ohio, Sept. 9, 2013 /PRNewswire/ -- Assurex Health, a personalized medicine company specializing in pharmacogenomics for neuropsychiatric and other disorders, today announced that Procter & Gamble veteran Virginia "Gina" Coleman Drosos has joined its leadership team in the role of President.

(Photo: http://photos.prnewswire.com/prnh/20130909/CL75940)
(Logo: http://photos.prnewswire.com/prnh/20130910/CL75944LOGO)  

Drosos joins Assurex Health with more than 25 years of global business leadership, innovation, operations and consumer marketing expertise. During her 25 year career at The Procter & Gamble Company (PG), Gina held positions of increasing responsibility in the United States and internationally delivering strong proven results.  She most recently served P&G as Group President for Global Beauty Care, a $6 billion global business unit with over 6,000 employees in 120 countries. 

"Gina brings extensive leadership and strong results on global consumer-driven businesses," said James S. Burns, CEO of Assurex Health.  "I'm particularly excited about Gina joining the team because health care is rapidly moving into an era of patient-empowerment, leading a shift to consumer-enabled personalized medicine.  In bringing neuropsychiatric pharmacogenomics to a market of 40+ million patients in the U.S. alone, Assurex will benefit from Gina's experience in creating awareness and cultivating a huge base of patients/consumers/caregivers, 80% of whom are women as the primary medical decision maker."

Assurex Health's pharmacogenomic technology is a breakthrough in personalized medicine.  Based on each patient's personal genetic profile, GeneSight tests help clinicians determine the right treatment medications for patients with depression, ADHD, chronic pain and other neuropsychiatric disorders. "Eliminating today's typical trial and error process for selecting medications can help people reclaim their lives and reduces healthcare costs," said Drosos.  "I look forward to applying my experience leading in the consumer space to help make personalized medicine a standard of care in the industry.  With exciting new innovations in the pipeline and our technology-information-consumer platform, I'm confident Assurex will help more physicians and practitioners determine the best treatment options and lead the movement toward consumer-enabled personalized medicine."

Drosos also serves on the Board of Directors for several major corporations including Signet Jewelers Ltd. (SIG) and American Financial Group (AFG).  Drosos earned a Bachelor of Business Administration in Finance from the University of Georgia, a Master of Business Administration from The Wharton School, University of Pennsylvania, and was recognized as one of Fortune's 50 Most Powerful Women in Business in 2010 and 2011.

About Assurex Health
Assurex Health is a personalized medicine company that specializes in pharmacogenomics and is dedicated to helping physicians determine the right medication for individual patients suffering from neuropsychiatric and other disorders. The company was founded in 2006 to commercialize industry-leading personalized medicine technology developed by Assurex Health based on technology licensed from Mayo Clinic and Cincinnati Children's Hospital Medical Center who remain technology collaborators.  For more information about Assurex Health, visit www.assurexhealth.com.

About GeneSight
GeneSight is a laboratory developed pharmacogenomic test that uses cutting edge technology to measure and analyze clinically important genomic variants in the treatment of psychiatric disorders and pain. The results of the GeneSight report can help a clinician understand the way a patient's unique genomic makeup may affect the effectiveness of certain psychiatric medications. The analysis is based on pharmacogenomics, the study of genomic factors that influence an individual's response to drug treatments, FDA approved manufacturer's drug labels, peer-reviewed scientific and clinical publications, and proven drug pharmacology. Quick turnaround time, combined with a customized report of the patient's genomic makeup, clinical experience and other factors can help a physician make better personalized drug treatment choices for each patient.


'/>"/>
SOURCE Assurex Health
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Assurex Health Appoints Chief Financial Officer and Payer Market Executive to Manage Rapid Growth in Personalized Medicine
2. Omeros to Present at the Stifel Healthcare Conference 2013
3. FDA approves drug tested by Scottsdale Healthcare and TGen
4. Orexigen Therapeutics to Present at the Bank of America Merrill Lynch Global Healthcare Conference
5. Quest Diagnostics to Speak at the Morgan Stanley Global Healthcare Conference
6. Shire to Present at the Morgan Stanley Global Healthcare Conference
7. Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch Global Healthcare Conference
8. Sorrento Therapeutics to Present at Two Healthcare Conferences
9. Rigel to Present at Stifel Healthcare Conference
10. BioDelivery Sciences to Present at the Stifel Nicolaus 2013 Healthcare Conference
11. Lexicon To Present At The Stifel Nicolaus Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... 9, 2016 QGEN ... den Abschluss eines Kooperationsvertrags mit 10x Genomics ... in den Bereichen Next-Generation-Sequencing (NGS), Single-Cell-Biology und ... Frankfurt Prime Standard: QIA) gab heute den ... die Entwicklung und Förderung umfassender Lösungen in ...
(Date:2/9/2016)... 2016   AllCare Plus Pharmacy announced today ... of Approval ® for Home Care Accreditation ... The Gold Seal of Approval ® is a ... providing safe and effective care.  ... a rigorous on-site survey in January 2016. The survey ...
(Date:2/9/2016)... 9, 2016 The leader in accelerated orthodontics, ... is the recipient of the 2015 Townie Choice ... Class II medical device that speeds up orthodontic tooth ... pain often associated with treatment, AcceleDent was selected by ... annual Orthotown survey of the most reliable ...
Breaking Medicine Technology:
(Date:2/9/2016)... ... February 09, 2016 , ... ... Elder-Beerman, Herberger’s and Younkers department stores, announced it has raised $176,000 to benefit ... Center, Holden Comprehensive Cancer Center at the University of Iowa, The Lynn Sage ...
(Date:2/9/2016)... Maui, Hawaii (PRWEB) , ... February 09, 2016 , ... ... to Maui to lead a photographic adventure on the island, June 14-19, 2016, hosted ... Unforgettable Events series. , After a successful debut in 2015, the ...
(Date:2/9/2016)... ... February 09, 2016 , ... The Brain Preservation Foundation’s ... team from 21st Century Medicine (21CM) ( http://www.21cm.com/ ), spearheaded by recent ... circuits of an intact rabbit brain for extremely long-term storage using a combination ...
(Date:2/8/2016)... LA (PRWEB) , ... February 08, 2016 , ... ... from offices in Houma, LA, celebrates the beginning of a new charity campaign. ... to assist Court Appointed Special Advocates (CASA). In the belief that children deserve ...
(Date:2/8/2016)... N.J. (PRWEB) , ... February 08, 2016 , ... ... protective footwear and clothing, announced expansion into Canada to provide its range of ... opened a sales office in Quebec City that will provide bilingual customer service ...
Breaking Medicine News(10 mins):